PleXus Communications
PleXus Communications: Delivering quality online CME/CE accredited activities to meet the educational needs of oncology and hematology healthcare providers.
Videos
PleXus Communications
Myeloma Rounds: Asymptomatic Patient With High-Risk SMM
FEATURING
Nirav Antao,
Patrick Hagen
- 107 views
- November 28, 2023
PleXus Communications
Myeloma Rounds: Patient With SMM Enrolled in the DETER-SMM Trial
FEATURING
Nirav Antao
- 78 views
- November 27, 2023
PleXus Communications
Why We Should Not Treat SMM
FEATURING
Ben Derman
- 414 views
- November 27, 2023
- 2
PleXus Communications
Adverse Effects of Treatment for mCSPC and Their Multidisciplinary Management
FEATURING
Grace Cullen
- 83 views
- October 4, 2023
PleXus Communications
Advancing Care for Veterans: No Longer Settling for "Enough" - Enhancing Treatment of HSPC
FEATURING
Matthew Rettig
- 83 views
- October 3, 2023
- 1
PleXus Communications
Improving Bladder Cancer Outcomes by Integrating New Knowledge Into Clinical Practice
FEATURING
Matthew Galsky
- 150 views
- July 18, 2023
PleXus Communications
Low-Risk MDS in Community Practice: How Recent Advances Will Benefit Your Patients
FEATURING
Guillermo Garcia-Manero
- 292 views
- July 16, 2023
- 1
PleXus Communications
Changing Pharmacological Paradigms for Higher-Risk Myelofibrosis
FEATURING
Raajit Rampal
- 199 views
- July 14, 2023
- 2
PleXus Communications
Exploring the Evolving and Expanding Role of CAR T-Cell Therapies in the Treatment of B-Cell Lymphoma
FEATURING
Jeremy Abramson
- 83 views
- July 14, 2023
PleXus Communications
Managing Women's Health in Menopause: Evolving Approaches for the Management of Vasomotor Symptoms
- 2,714 views
- April 3, 2023
- 18
PleXus Communications
Optimizing Androgen Deprivation Therapy in Advanced Prostate Cancer
FEATURING
Neal Shore
- 180 views
- March 10, 2023
- 1
PleXus Communications
Fine Tuning Anti-BCMA Therapies in MM
FEATURING
Jennifer Cooperrider
- 18 views
- February 14, 2023
PleXus Communications
Infections in Patients With MM in the Modern Era
FEATURING
Alice Han
- 118 views
- February 14, 2023
- 1
PleXus Communications
Evolving Clinical Perspectives for High-Risk and R/R AML Management
FEATURING
Amer Zeidan
- 31 views
- December 7, 2022
PleXus Communications
Clinical Practices for Optimizing the Use of BTK Inhibitors for the Treatment of CLL
FEATURING
Matthew Davids
- 127 views
- December 6, 2022
PleXus Communications
Treatment Intensification Strategies to Improve Outcomes of Patients With mHSPC
FEATURING
Julie Graff
- 33 views
- December 6, 2022
PleXus Communications
Adverse Effects of Treatment for mHSPC and Their Multidisciplinary Management
FEATURING
Grace Cullen
- 34 views
- December 6, 2022
PleXus Communications
Diagnosis and Risk Stratification Considerations for MM
FEATURING
Amrita Krishnan
- 31 views
- November 24, 2022
PleXus Communications
Evolving Concepts of Managing Newly Diagnosed Multiple Myeloma Patients
FEATURING
Ola Landgren
- 37 views
- November 24, 2022
PleXus Communications
Relapsed and Refractory MM: Choosing the Right Treatment
FEATURING
Sagar Lonial
- 116 views
- November 24, 2022
PleXus Communications
CAR T-Cell Therapy for Relapsed MM
FEATURING
Amrita Krishnan
- 14 views
- November 24, 2022
PleXus Communications
Advances in Targeted Therapies for NSCLC: Optimizing Patient Outcomes
FEATURING
Millie Das
- 63 views
- November 11, 2022
- 1
PleXus Communications
B-Cell Non-Hodgkin Lymphomas: Integrating Recent Treatment Advances Into Clinical Practice
FEATURING
Ian Flinn
- 117 views
- November 11, 2022
PleXus Communications
Recent Advances and Evidence-Based Clinical Practices to Optimize Care in Beta Thalassemia
FEATURING
Shivi Jain
- 44 views
- November 11, 2022
PleXus Communications
The Evolving Treatment Landscape for Higher-Risk MDS
FEATURING
Jamile Shammo
- 39 views
- June 14, 2022
PleXus Communications
Expert Perspectives on Treating High-Risk and R/R AML
FEATURING
Eytan Stein
- 135 views
- June 6, 2022
- 1
PleXus Communications
Management of Waldenstrom's Macroglobulinemia in the Era of Targeted Therapies
FEATURING
Steven Treon
- 57 views
- June 6, 2022
- 1
PleXus Communications
Optimizing the Care of Mantle Cell Lymphoma: Translating the Latest Advances Into Clinical Practice
FEATURING
Jonathon Cohen
- 81 views
- May 20, 2022
PleXus Communications
Advances in CAR T-Cell Therapies: Optimizing Outcomes and Implementation in Hematologic Malignancies
FEATURING
Caron Jacobson
- 154 views
- May 20, 2022
PleXus Communications
Understanding Evoloving Treatment Strategies in NDMM Patients
FEATURING
Ben Derman
- 36 views
- April 1, 2022
PleXus Communications
Expert Perspectives on Optimizing Outcomes With the Latest Advances in Small Molecule Inhibitors for CLL
FEATURING
Matthew Davids
- 158 views
- April 1, 2022
PleXus Communications
Shifting Paradigms in the Management of Advanced Urothelial Carcinoma
FEATURING
Ulka Vaishampayan
- 90 views
- March 29, 2022
PleXus Communications
2022 Updates on Navigating the Continuum of Care for Advanced Prostate Cancer (mCSPC, CRPC)
FEATURING
Matthew Rettig
- 98 views
- March 2, 2022
PleXus Communications
Emerging Cellular and Targeted Therapy Options for the Management of Large B-Cell Lymphomas
FEATURING
Caron Jacobson
- 156 views
- February 15, 2022
PleXus Communications
HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors
FEATURING
Komal Jhaveri
- 324 views
- February 9, 2022